What is primary biliary cirrhosis and how to manage this deadly disease?
Primary biliary cirrhosis, or primary biliary cholangitis (PBC), is a chronic liver disease in which the bile duct in the liver is damaged and causes inflammation in the liver. PBC gradually leads to a build-up of bile in the liver, which causes damage to liver cells and this eventually leads to scarring, also known as cirrhosis.
The exact cause of PBC is unknown, but it may be related to a problem with the immune system, which is the body's natural defense system. Much like other forms of liver disease, many PBC patients do not have symptoms until the later stages, making it difficult to treat. When symptoms do occur, they may include:
- Itching
- Fatigue
- Jaundice
- Pain around the liver area (upper right abdomen)
Treatment options
As the cause of PBC is yet to be discovered, treatment options are limited and medications are usually used to help slow disease progression and manage symptoms. Medications for PBC aim to control bile acid; by leading bile out of the liver, inflammation and damages caused to liver cells may be reduced. Medication treatment is not intended to cure PBC but rather, it requires long term usage, causing various other problems to PBC patients.
Long term medication often places extra burden on the liver, although it might help the liver to reduce injury caused by bile duct damage, at the same time, the medication itself is actually damaging to liver function. Medication is therefore not ideal to be used for long periods. Moreover, the effectiveness of the medication is only around 50%, considering other issues such as side effects; medication treatment may not always be the best and most suitable option for patients with PBC.
Another approach to PBC?
In Chinese Medical or Kampo Medical theory, liver problems and liver inflammation are often caused by blockage in the liver, when the circulation is somehow disturbed causing toxins to build up, finally leading to damage. To solve this problem, patients must focus on regaining the balance and circulation in the liver, of which YHK therapy can help.
YHK is a natural yet scientific based liver therapy, it was created by Kampo and natural health maintenance expert - Prof. Sha, and Medical Doctor - Prof. Noboru. Research and clinical data show that YHK can effectively heal liver damage, prevent liver injury, stop inflammation and also reverse fibrosis in the liver. The patented formula of YHK consists of 4 natural ingredients which are designed to help to improve blood quality in the liver and rebuild the circulation.
For more information about YHK’s research data on PubMed:
https://www.ncbi.nlm.nih.gov/pubmed/?term=YHK+marotta
All of YHK’s research data: http://www.yhktherapy.com/en/scientific-data.php
PBC patient achieve good results with YHK
Linda, a patient with PBC and fatty liver who has used YHK to rebuild liver health and prevent liver injury found YHK to be effective in helping her to recover:
“I was diagnosed with a fatty liver and tested for PBC, Primary Biliary Cholangitis and the hepatologist told me there was nothing I could do except to lose weight. I was determined to prove him wrong and researched fatty liver and PBC.
I came across your website and ordered the YHK tablets. Since both my AST and ALT were elevated however not extremely high, I only took one tablet upon rising on an empty stomach and one tablet before bed.
And Yes!! After taking it for six months, my blood work showed that all my liver enzymes had returned to normal and they no longer are concerned about my liver! I got my stamina back and no longer feel lethargic which was one of the symptoms to having a fatty liver or PBC. My skin looks good and I have the desire to return to the gym.
For my ALT and AST Levels, they both dropped 40 points without any side effects and are now within normal range. Attached with my most recent report.
Also, excellent support team and the personalized service is most impressive and a reason that I am a repeat customer.”
- Linda O. from USA
- Linda started YHK in Dec 2016
- Review submitted on: 2017-06-21
- Latest report shows normal ALT (26) and AST (24) levels.
- * All research and clinical data should be used as reference purposes only, results may vary.